A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Our Company IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. We are committed to using artificial intelligence ("AI") responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | % of Total |
|---|---|---|---|---|---|---|
Research & Development Solutions | $7.56B | $7.92B | $8.39B | $8.53B | $8.90B | 29% |
Operating Segments | $7.56B | $7.92B | $8.39B | $8.53B | $8.90B | 29% |
Technology & Analytics Solutions | $5.53B | $5.75B | $5.86B | $6.16B | $6.63B | 22% |
Europe and Africa | $2.28B | $2.17B | $2.16B | $2.40B | $2.65B | 9% |
Asia-Pacific | $1.77B | $2.16B | $2.13B | $2.33B | $2.52B | 8% |
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 16.3B | 16.3B | 15.4B | 15.0B | 14.4B | 13.9B |
| Net Income | 1.4B | 1.4B | 1.4B | 1.4B | 1.1B | 966M |
| EPS | $7.84 | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 |
| Free Cash Flow | 2.1B | 2.1B | 2.1B | 1.5B | 1.6B | 2.3B |
| ROIC | 8.3% | 8.8% | 9.2% | 9.6% | 8.3% | 7.0% |
| Gross Margin | 33.3% | 33.3% | 34.9% | 35.0% | 34.9% | 33.5% |
| Debt/Equity | 2.74 | 2.74 | 2.52 | 2.39 | 2.28 | 2.07 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | 2.2B | 2.2B | 2.2B | 2.0B | 1.8B | 1.4B |
| Operating Margin | 13.4% | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% |
| ROE | 20.9% | 21.6% | 22.6% | 22.2% | 18.9% | 16.0% |
| Shares Outstanding | 173M | 173M | 183M | 186M | 191M | 195M |
IQVIA HOLDINGS INC. passes 6 of 9 quality checks, suggesting mixed fundamentals.
IQVIA HOLDINGS INC. trades at 21.9x trailing earnings, compared to its 15-year median P/E of 33.6x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 14.2x vs a median of 24.9x. The company's 5-year average ROIC is 8.6% with a gross margin of 34.3%. Total shareholder yield (buybacks) is 4.2%. At current prices, the estimated annualized return to fair value is +17.4%.
IQVIA HOLDINGS INC. (IQV) has a current P/E ratio of 21.9, compared to its historical median P/E of 33.6. The stock is currently considered Fair based on its historical valuation range.
IQVIA HOLDINGS INC. (IQV) has a 5-year average return on invested capital (ROIC) of 8.6%. This is below average and may indicate limited pricing power.
IQVIA HOLDINGS INC. (IQV) has a market capitalization of $29.8B. It is classified as a large-cap stock.
IQVIA HOLDINGS INC. (IQV) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 4.17%.
Based on historical P/E analysis, IQVIA HOLDINGS INC. (IQV) appears fair. The current P/E of 21.9 is 35% below its historical median of 33.6. The estimated fair value CAGR (P/E method) is 37.3%.
IQVIA HOLDINGS INC. (IQV) operates in the Services-Commercial Physical & Biological Research industry, within the Industrials sector.
IQVIA HOLDINGS INC. (IQV) reported annual revenue of $16.3 billion in its most recent fiscal year, based on SEC EDGAR filings.
IQVIA HOLDINGS INC. (IQV) has a net profit margin of 8.3%. This is a modest margin.
IQVIA HOLDINGS INC. (IQV) generated $2.1 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
IQVIA HOLDINGS INC. (IQV) has a debt-to-equity ratio of 2.74. This indicates higher leverage, which may increase financial risk.
IQVIA HOLDINGS INC. (IQV) reported earnings per share (EPS) of $7.84 in its most recent fiscal year.
IQVIA HOLDINGS INC. (IQV) has a return on equity (ROE) of 21.6%. This indicates the company generates strong returns for shareholders.
IQVIA HOLDINGS INC. (IQV) has a 5-year average gross margin of 34.3%. This indicates decent pricing power.
The Ledger Terminal provides 15 years of financial data for IQVIA HOLDINGS INC. (IQV), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
IQVIA HOLDINGS INC. (IQV) has a book value per share of $37.49, based on its most recent annual SEC filing.